Bill Gates, Global Health, and the Rise of Private Influence
He doesn’t sit in the World Health Assembly. He doesn’t hold a government post. He was never elected to anything.
And yet, for the better part of two decades, decisions about which diseases matter, which vaccines get built, which researchers get funded, and which health systems get reshaped have run, again and again, through one man’s foundation.
This is not a conspiracy theory. It’s a paper trail. And the paper trail leads to an uncomfortable conclusion: a private citizen has accumulated more sway over global health policy than most of the world’s governments, without ever facing an election, a recall, or a vote of no confidence.
THE MONEY
In 2025 alone, the Gates Foundation moved $8.47 billion through its charitable machine. Nearly $1.9 billion of that went straight into global health: $474 million for immunization, $749 million for polio, $321 million for malaria, $258 million for HIV, $215 million for tuberculosis, $189 million for vaccine development. Another $364 million went to “Global Policy & Advocacy,” a line item that, translated, means shaping what governments and institutions believe and do.
And this is only the beginning. In May 2025 the foundation announced it intends to spend more than $200 billion between now and 2045, with Gates giving away virtually his entire fortune through the institution that bears his name.
That is not charity in the traditional sense of writing checks to relieve suffering. That is the deliberate, decades-long construction of a private empire of influence over the health of billions of people who never agreed to be governed by it.
BUYING A SEAT WHERE NO ONE ELECTED HIM
The World Health Organization likes to describe itself as a member-state body, accountable to the nations that fund and govern it. In practice, that democratic veneer is thinner than it looks.
By WHO’s own admission, mandatory dues from member states, the money attached to no strings and no donor preferences, cover only around 16% of its budget. The rest comes from voluntary, largely earmarked contributions, and nearly 10% of the entire WHO budget flows from private philanthropic foundations, above all the Gates Foundation. WHO itself has conceded that this dependence on voluntary, earmarked money constrains its ability to set its own agenda.
Put plainly: the organization tasked with setting global health priorities cannot fully control its own priorities, because a private billionaire’s foundation supplies the money that fills the gap.
A 2025 study in BMJ Global Health quantified exactly what that has meant. Between 2000 and 2024, the Gates Foundation funneled roughly $5.5 billion into WHO across 640 separate grants, 9.5% of WHO’s entire revenue over more than a decade. Of that $5.5 billion, 82.6% was funneled into infectious disease alone, and a staggering 58.9% of all Gates money to WHO went to a single cause: polio. One man’s priorities, replicated at the scale of a UN agency’s budget.
This is not “influence” in some abstract, deniable sense. It is a foundation buying its way into determining which diseases the world’s premier health institution treats as urgent, and which it doesn’t.
THE BILLIONAIRE ON THE BOARD
If WHO’s dependency is uncomfortable, Gavi, the Vaccine Alliance, is where the mask comes fully off. Gates isn’t an outside donor pulling strings from a distance here; he has a literal seat at the table. The foundation has committed $1.55 billion to Gavi’s 2016-2025 strategy and another $1.6 billion for 2021-2025, plus $150 million for COVAX. In exchange, the Gates Foundation holds a permanent, formally recognized seat on Gavi’s Board and its Governance Committee, currently occupied by Greg Widmyer, with Sue Graves as alternate.
No one voted for Widmyer. No public in any country was consulted before a philanthropist’s employee was handed permanent governance authority over an institution that decides which vaccines reach which children, in which countries, on whose schedule.
Defenders call this “multistakeholder governance.” Critics call it something blunter. During the 2021 fight over COVID vaccine patents, when the world was watching people die in India and Brazil for lack of vaccine access, Nick Dearden, director of Global Justice Now, didn’t mince words about who was really calling the shots in global health. He called Gates’s opposition to sharing vaccine technology “disgusting,” and asked pointedly:
Who appointed this billionaire head of global health? Oh yeah, he did.
THE POLIO PARADOX, AND THE PATENT FIGHT
Gates’s defenders point to results: polio cases down, diseases in retreat. But results are not the same as legitimacy, and the same concentration of money that produces results can also produce a chokehold.
Take the 2021 vaccine patent waiver fight, arguably the single clearest moment the world got to see private philanthropic power collide directly with public need. As COVID tore through India and Brazil, more than 100 countries backed a proposal at the WTO to temporarily waive intellectual property protections on vaccines, so poorer nations could manufacture their own supply. Gates, described by South Africa’s Mail & Guardian at the time as “the most influential non-state actor in global public health,” opposed it. Asked directly by Sky News whether sharing the vaccine “recipe” would help, Gates said no, arguing that manufacturing capacity, not intellectual property, was the real bottleneck.
The backlash was immediate and furious. The AIDS Healthcare Foundation accused him of applying the same “heartless IT robber baron approach” he’d used running Microsoft to a global pandemic. Guardian journalist Stephen Buryani wrote that Gates “acts like an optimist but has a truly dismal vision of the world.” Only after sustained international pressure, from governments, from advocacy groups, from the sheer weight of a rising death toll, did the foundation reverse course and back a “narrow” waiver.
That reversal is often cited as proof the system works. Look closer, and it proves the opposite: for months, one private citizen’s opinion on intellectual property functioned as a de facto veto on a policy backed by a majority of the world’s governments. It took a global outcry to move him. Most policy disagreements never generate that kind of outcry, which means most of the time, his position simply prevails by default.
THE RESEARCH ECOSYSTEM THAT BENDS TOWARD HIM
Money this concentrated doesn’t just buy programs. It buys gravity, the kind that bends an entire field around it.
When one foundation is capable of funding laboratories, staffing research institutions, seeding clinical trials, and financing the international bodies that later cite that research to justify policy, “independence” becomes a technicality. Researchers do not need to be corrupt to orient their careers toward where the money is. They simply need to be rational. The result, over enough years, is a global health research agenda that reflects one man’s priorities (vaccines, infectious disease, technological fixes) while chronic disease, health systems strengthening, and locally-defined priorities in the Global South compete for scraps.
Investigative journalist Tim Schwab spent years documenting exactly this dynamic in his 2024 book, The Bill Gates Problem: Reckoning with the Myth of the Good Billionaire. Reviewers and fellow journalists who covered the book didn’t shy away from its central charge: that Gates’s philanthropy functions as a way of buying a seat at the democratic decision-making table, shaping public policy on everything from public health to public education without ever facing the accountability that comes with holding office. One blurb on the book put the underlying question even more starkly:
Should a secretive, unaccountable billionaire dictate policy in public health, education, and science at all?
Schwab wasn’t speaking in a vacuum. He built the case over years of reporting for The Nation, the Columbia Journalism Review, and the British Medical Journal, outlets not known for reflexive billionaire-bashing, and has since discussed the foundation’s reach at events with researchers and activists who’ve spent two decades tracking it, from AGRA Watch’s Ashley Fent to University of Washington global health faculty. The through-line of their critique: a foundation that presents itself as a neutral technical partner while functioning, in practice, as an unelected policy actor with a preference for market-based, patent-protected, technology-driven solutions, and the resources to make those preferences reality.
AFRICA: WHERE THE ASYMMETRY IS STARKEST
Nowhere is the imbalance more visible than in Africa, where the people affected by Gates Foundation decisions are rarely in the room when those decisions are made. Between 2020 and 2023, Africa received $17.6 billion in cross-border philanthropic funding, a third of the global total, and the Gates Foundation and the Mastercard Foundation together accounted for more than half of it. Health took the largest share of that money globally.
A single philanthropist headquartered in Seattle now has more influence over what counts as a health priority across dozens of African nations than most of the finance ministers actually representing those nations’ populations. That is not a metaphor. It is a structural fact about where the money, and therefore the leverage, sits.
NO VOTE, NO RECALL, NO ACCOUNTABILITY
Here is the mechanism that makes all of this possible, and all of this dangerous: a government can be voted out. A health minister can be hauled before a legislature. A public agency answers, eventually, to courts and to citizens.
A private foundation answers to none of that. The Gates Foundation has a board, but no affected community anywhere in the world can vote that board out. It has “governance,” but no global electorate that can rewrite its strategy when it gets something wrong. Academic researchers studying the foundation have described this precise imbalance as a problem of domination: the capacity of concentrated private wealth to shape the institutions and interests of people who have no mechanism to contest the decisions made on their behalf.
Publishing a grants database does not fix this. Transparency tells you where the money went. It does not tell you who decided it should go there, who was overruled, or who never got a vote in the first place.
THE VACUUM HE’S MOVING INTO
And the trend line is not toward less concentration, it’s toward more. The United States formally withdrew from the WHO in January 2026, pulling its funding and its membership with it. WHO is already warning of the financial fallout. Gavi has faced its own funding shortfalls. As public money retreats from global health, there is only one actor positioned, by cash reserves, by institutional relationships, by decades of embedded influence, to fill the resulting vacuum: a single private foundation with a stated 20 year, $200 billion plan already in motion.
Every dollar of retreating public funding is an invitation for that private influence to expand further, with even less competition and even less scrutiny than it already enjoys.
THE QUESTION THAT MATTERS
Yes there are serious claims that Bill Gates issues secret orders to WHO or personally dictates a country’s vaccine schedule, but that was never the real question, and pretending otherwise is a distraction the foundation’s defenders are happy to let people chase.
The real question is the one Nick Dearden asked out loud in 2021: who appointed this billionaire head of global health? The honest answer is that no one did, he simply had enough money to make the question academic. A foundation built on one man’s fortune now sits on the boards that govern vaccine access, supplies a tenth of the WHO’s budget with strings attached, shapes what gets researched and what doesn’t, and is preparing to spend $200 billion more over the next twenty years, all without a single mechanism by which the billions of people affected by its choices could ever vote it out, overrule it, or hold it to account.
That is not conspiracy. It is simply what unaccountable concentrated wealth looks like when it puts on the language of charity.
